DEFR14A: TETE Seeks Another Extension for Business Combination

Technology & Telecommunication Acquisition Corporation (TETE) is seeking shareholder approval to extend its business combination deadline by three months to November 20, 2025, to finalize a merger with Bradbury Capital Holdings Inc.

Summary

• TETE is holding an Extraordinary General Meeting on August 20, 2025, to vote on extending its business combination period.
• The proposed extension would amend the company's Articles of Association and Trust Agreement, moving the deadline from August 20, 2025, to November 20, 2025.
• The Board believes more time is needed to hold a shareholder vote and consummate the proposed business combination with Bradbury Capital Holdings Inc.
• Without the extension, TETE faces a significant risk of liquidation, which would result in public shareholders receiving a pro rata share of the trust account and warrants expiring worthless.
• As of May 31, 2025, the redemption price per Public Share was approximately $12.71, based on a Trust Account balance of approximately $7,258,933 and 570,982 Public Shares outstanding.
• The closing price of Public Shares on the OTC Pink Market on May 30, 2025, was $12.00, meaning redemption offers a premium of $0.71 per share over the market price.
• The Sponsor has previously loaned the company an aggregate of $2,817,736 for extension payments as of May 31, 2025, convertible into 281,773 TETE Units at $10.00 per unit upon business combination consummation.
• Previous shareholder meetings saw significant redemptions: 8,373,932 shares ($86,353,662) on January 18, 2023; 149,359 shares ($1,626,736.79) on July 18, 2023; 408,469 shares ($4,872,513.12) on June 7, 2024; 1,993,697 shares ($24,739,495.83) on January 20, 2025; and 3,561 shares ($45,060.56) on April 16, 2025.
• Non-redemption agreements were entered into with institutional investors in January and April 2025, involving potential share forfeitures by the Sponsor and issuance of new shares or cash payments to investors post-combination.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative. While the board is working to complete a business combination and offers a redemption premium, the repeated need for extensions, significant past redemptions, and delisting from Nasdaq indicate substantial challenges and a prolonged, uncertain path to a deal. The risk of liquidation remains high if the extension is not approved or a deal isn't closed by the new deadline.

Positives

• The Board unanimously recommends approving the extension, indicating a continued commitment to completing a business combination.
• The redemption price of approximately $12.71 per Public Share is higher than the market price of $12.00 as of May 30, 2025, offering a guaranteed return for redeeming shareholders.
• The company has a definitive agreement for a proposed business combination with Bradbury Capital Holdings Inc., suggesting a target has been identified.

Negatives

• This is another request for an extension, following multiple previous extensions, indicating persistent challenges in closing a business combination.
• Significant shareholder redemptions have occurred in prior extension votes, substantially reducing the funds in the Trust Account.
• The company's securities were delisted from Nasdaq and now trade on the OTC Pink Market, which can lead to reduced liquidity and investor interest.
• The Sponsor and management have significant financial interests tied to the completion of a business combination, which may differ from public shareholders' interests.
• Warrants will expire worthless if a business combination is not consummated and the company liquidates.

Risks

• Failure to obtain shareholder approval for the extension will force the company to liquidate, resulting in warrants expiring worthless and public shareholders receiving only their pro rata share of the trust account.
• The company may be deemed an unregistered investment company under the Investment Company Act of 1940, potentially forcing liquidation and rendering warrants worthless.
• The Sponsor's control by a Malaysian citizen (Tek Che Ng) may subject a business combination with a U.S. target to review by CFIUS, which could block or delay the transaction.
• Delisting from Nasdaq to the OTC Pink Market results in limited market quotations, reduced liquidity, and decreased ability to raise additional capital, making it harder to consummate a business combination.
• The market price of Public Shares may not have sufficient liquidity for shareholders to sell their shares in the open market, even if the market price is lower than the redemption price.
• Redemptions reduce the amount in the Trust Account, which could make the company less attractive to potential target businesses and increase the percentage interest of the Sponsor and management.

Future Outlook

The company intends to continue its efforts to consummate a business combination with Bradbury Capital Holdings Inc. by the proposed Extended Date of November 20, 2025, if the extension proposals are approved. A separate extraordinary general meeting will be held at a future date to approve the business combination itself.

Management Comments

• "Our board of directors currently believes that there will not be sufficient time before August 20, 2025 to hold a general meeting at which to conduct a vote for shareholder approval of the Proposed Business Combination."
• "Our board of directors has determined it is in the best interests of the Company and our shareholders to extend the termination date from August 20, 2025 to the Extended Date."
• "Without the Extension, TETE believes that there is a significant risk that TETE will not, despite its best efforts, be able to complete a Business Combination on or before the Termination Date."
• "TETE believes a Business Combination will provide significant benefits to its shareholders."
• The Board unanimously recommends that shareholders vote FOR the Extension Amendment Proposal, the Trust Agreement Amendment Proposal, and the Adjournment Proposal.

Industry Context

The filing reflects a common trend in the SPAC industry where companies frequently seek extensions to their business combination deadlines due to the complexities and time-consuming nature of identifying and closing suitable merger targets. The history of high redemption rates and the delisting from Nasdaq to the OTC Pink Market are indicative of the challenges many SPACs face, particularly those struggling to secure a deal within their initial timelines or maintain exchange listing requirements. The need for multiple extensions and the reliance on sponsor funding for these extensions highlight the financial pressures and reduced investor confidence often seen in SPACs nearing their liquidation deadline.

Comparison to Industry Standards

• The repeated need for extensions and the high redemption rates (e.g., 8.3 million shares in January 2023, 1.9 million shares in January 2025) are significantly higher than the average for successful SPACs, which typically complete their mergers with fewer extensions and lower redemptions.
• The delisting from Nasdaq to the OTC Pink Market is a severe negative indicator, contrasting sharply with SPACs that successfully complete de-SPAC transactions and maintain or upgrade their listing on major exchanges.
• The redemption price of $12.71 being higher than the market price of $12.00 is a common characteristic of SPACs nearing their liquidation deadline, where the trust value provides a floor for public shareholders, often exceeding the trading price due to market skepticism about deal completion.
• The non-redemption agreements, involving share forfeitures by the Sponsor and issuance to institutional investors, are a mechanism sometimes used by SPACs to manage redemptions and ensure sufficient capital remains for a business combination, though they also highlight the difficulty in retaining public shareholder capital.

Corporate Governance

Related Party Transactions

• The Sponsor has loaned the company $2,817,736 for extension payments, convertible into 281,773 TETE Units at $10.00 per unit upon business combination consummation. These loans are non-interest bearing.
• Non-redemption agreements with the Sponsor and institutional investors involve the Sponsor forfeiting shares and the company issuing new shares or making cash payments to investors post-closing, contingent on the business combination.

Stakeholder Impact

• **Shareholders (Public)**: Face a decision between redeeming shares at a premium to market price or holding for potential upside from a business combination, with the risk of further delays or liquidation. Their percentage ownership will increase if redemptions occur.
• **Shareholders (Sponsor/Initial)**: Have significant financial interests tied to the completion of a business combination, as their Founder Shares and private placement units would be worthless upon liquidation. They bear the cost of extensions through loans.
• **Customers/Suppliers/Creditors**: No direct impact mentioned, but continued uncertainty about the company's future could indirectly affect relationships if a business combination is not completed.

Next Steps

• Hold an Extraordinary General Meeting on August 20, 2025, to vote on the Extension Amendment Proposal, Trust Agreement Amendment Proposal, and Adjournment Proposal.
• If approved, file the amended and restated Articles of Association with the Cayman Islands Registrar of Companies.
• Continue efforts to consummate a business combination with Bradbury Capital Holdings Inc. by the Extended Date of November 20, 2025.
• Call an additional extraordinary general meeting at a future date to approve the proposed business combination itself.

Key Dates

Recommendation

The recommendation is 'hold' for public shareholders who have not yet redeemed. While the company faces significant challenges, including repeated extensions, high past redemptions, and delisting, the current redemption price of $12.71 offers a premium over the market price of $12.00. This provides a floor for the investment. Shareholders should 'hold' to either redeem at the premium if the extension is approved and they choose to, or to participate in the potential upside of the proposed business combination with Bradbury Capital Holdings Inc. if it eventually closes. However, the history of delays and the delisting warrant caution against a 'buy' recommendation, and the option to redeem at a premium prevents a 'sell' recommendation for those who can still exercise redemption rights.

Keywords

SPAC, Extension, Business Combination, Redemption, Proxy Statement, SEC Filing, Technology & Telecommunication Acquisition Corporation, Bradbury Capital Holdings Inc., Trust Account, Liquidation, CFIUS, OTC Markets, Shareholder Vote